Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 15, 2021

SELL
$118.19 - $131.5 $3.16 Million - $3.51 Million
-26,714 Closed
0 $0
Q1 2021

Jun 21, 2021

SELL
$111.18 - $119.74 $5.06 Million - $5.45 Million
-45,546 Reduced 63.03%
26,714 $3.16 Million
Q4 2020

Feb 03, 2021

SELL
$100.57 - $117.14 $166,443 - $193,866
-1,655 Reduced 2.24%
72,260 $8.47 Million
Q3 2020

Nov 02, 2020

SELL
$90.13 - $108.78 $212,616 - $256,612
-2,359 Reduced 3.09%
73,915 $7.68 Million
Q2 2020

Jul 13, 2020

SELL
$84.11 - $103.33 $25,401 - $31,205
-302 Reduced 0.39%
76,274 $6.99 Million
Q1 2020

Apr 29, 2020

BUY
$72.92 - $121.3 $1.82 Million - $3.02 Million
24,933 Added 48.28%
76,576 $6.91 Million
Q4 2019

Jan 21, 2020

SELL
$104.49 - $114.54 $100,832 - $110,531
-965 Reduced 1.83%
51,643 $5.86 Million
Q3 2019

Nov 06, 2019

SELL
$98.02 - $111.18 $3.05 Million - $3.46 Million
-31,085 Reduced 37.14%
52,608 $5.71 Million
Q2 2019

Jul 19, 2019

BUY
$84.15 - $99.38 $136,154 - $160,796
1,618 Added 1.97%
83,693 $8.15 Million
Q1 2019

Jul 01, 2019

BUY
$82.45 - $93.79 $687,633 - $782,208
8,340 Added 11.31%
82,075 $7.48 Million
Q4 2018

Jan 15, 2019

SELL
$85.8 - $99.49 $9,952 - $11,540
-116 Reduced 0.16%
73,735 $6.71 Million
Q3 2018

Oct 23, 2018

SELL
$85.91 - $99.17 $60,222 - $69,518
-701 Reduced 0.94%
73,851 $7.27 Million
Q2 2018

Jul 19, 2018

SELL
$77.48 - $87.83 $362,838 - $411,307
-4,683 Reduced 5.91%
74,552 $6.38 Million
Q1 2018

Apr 20, 2018

BUY
$76.55 - $87.26 $5.64 Million - $6.43 Million
73,665 Added 1322.53%
79,235 $6.36 Million
Q4 2017

Feb 13, 2018

BUY
$76.93 - $83.5 $424,730 - $461,003
5,521 Added 11267.35%
5,570 $450,000
Q3 2017

May 03, 2018

BUY
$77.71 - $84.6 $3,807 - $4,145
49
49 $4,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Prentiss Smith & CO Inc Portfolio

Follow Prentiss Smith & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prentiss Smith & CO Inc with notifications on news.